PAX, a pioneering force in data-driven innovation, has embarked on an unprecedented journey to unravel the intricate relationship between cannabis and sleep. With a commitment to improving lives through consistent quality, memorable experiences, and a genuine reverence for the cannabis plant, PAX has taken a significant leap in advancing our understanding of how cannabis affects our sleep patterns. This announcement of their groundbreaking PAX sleep study, combines scientific rigor, medical expertise, and behavioral health insights to shine a light on the intricate relationship between cannabis and the quality of our slumber.
“We’re excited to bring the innovation we’re known for to a new formula that truly delivers improved sleep. Many Americans are sleep-deprived, which is having a significant impact on health and wellbeing,” said Brian Witlin, VP of Product Development at PAX. “While there are many cannabis sleep products on the market, our research is distinguished by its rigorous execution, overseen by a team of PhD experts, comprising both pharmacologists and toxicologists, spanning two years. The insights we gathered were remarkable, and we’re honored to pave the way for the entire sector with our findings and this novel product launch.”
Some of the most significant findings of the PAX Sleep Study suggest that commonly held beliefs around which cannabis products best support sleep are inconsistent with existing data.
For example, cannabinol (CBN) is frequently used in cannabis sleep products due to its sedative effect; however, research shows that it is in fact less effective than other cannabinoid profiles.
Additionally, consumers typically assume indicas will be the best sleep tools, but research suggests specific terpenes in combination with specific cannabinoids are a far better indicator of effect.
Sleep Crisis’ Detrimental Effect on Health and Wellbeing in the United States
- 50-70 million people in the U.S. have ongoing sleep disorders
- Less than one third of Americans get the recommended 7 hours of sleep
- Approximately 15% of US adults report insomnia that interferes with their daytime activities
- Nearly 10% of adults report taking sleep medications most days to fall or stay asleep
- Lack of sleep can cause increased risk of heart disease, diabetes, dementia, depression, obesity, weakened immune systems and accidents
The PAX Sleep Study: A Scientific Marvel
To comprehend the profound influence of cannabis on our sleep, PAX meticulously designed a set of randomized, crossover, single-blind controlled sleep studies. These comprehensive studies are bolstered by the meticulous scrutiny of PAX’s Health Advisory Board—an external team of distinguished experts in the fields of medicine, cannabinoid science, and behavioral health. The collaboration between these brilliant minds has paved the way for an empirical exploration of cannabis’s impact on sleep quality.
Participants and Controls: A Holistic Approach
The study was conducted with a cohort of 44 participants, ensuring a diverse and representative sample for comprehensive insights. The research design employed a multifaceted approach, featuring the following controls:
Cannabinoid-Only Control: This control group explored the effects of cannabinoids in isolation, shedding light on how these compounds influence sleep independently.
Benchmark Control: The benchmark control served as the point of reference, allowing researchers to gauge the impact of cannabinoids against a standard set of parameters.
Active Placebo Control: A placebo group with active elements provided valuable insights into the psychological aspects of cannabis’s influence on sleep.
Exploring the Diverse Formulations
The PAX study went a step further by delving into the impact of an array of proprietary formulations. These formulations were meticulously curated to offer a comprehensive understanding of the efficacy of various cannabis products in enhancing sleep quality.
Comprehensive Data Collection
The PAX study employed an impressive array of data collection methods to ensure a holistic analysis of the participants’ sleep experiences. The research harnessed the power of commercial wearables to collect biometric data, including factors such as heart rate variability and sleep duration. In addition, validated psychometric instruments were employed to obtain both qualitative and quantitative feedback. These instruments provided valuable insights into various aspects of sleep, including:
- Sleepiness
- Sleep Quality
- Anxiety and Depression
- Insomnia
- Duration and Quality of Sleep
The multi-pronged approach to data collection ensured that no aspect of sleep quality was left unexplored, making the PAX study an all-encompassing endeavor.
A Mission to Enhance Lives: PAX’s Dedication to Well-Being
PAX has delivered products that are not only simple and enjoyable but also trusted by millions around the world. Through its purpose-driven platform, “PEACE BY PAX,” the company supports social reform, advocates for safe access to cannabis, and champions sustainability.
The company’s mission is not only to create exceptional cannabis experiences but also to drive positive change in the world.
The PAX Study: A Step Towards Illuminating the Cannabis-Sleep Nexus
The PAX study is a testament to the company’s dedication to advancing our understanding of how cannabis can influence the quality of our sleep. By combining rigorous scientific methodology, the expertise of its Health Advisory Board, and a holistic approach to data collection, PAX has embarked on a mission to unlock the secrets of the cannabis-sleep relationship.
As the cannabis industry continues to evolve, PAX remains at the forefront, driving innovation and providing valuable insights that can enhance the lives of cannabis users.
For those interested in delving deeper into the impact of cannabis on sleep, the PAX sleep study promises to be an invaluable resource and can be read here.
*Based on an in-house study using biometric and validated psychometric instruments. For more information, visit pax.com/sleep. The FDA has not evaluated or approved these statements. This product is not intended to diagnose, treat, cure, or prevent any disease. Use only as directed.
